MedCity News January 16, 2020
In an interview at the J.P. Morgan Healthcare Conference in San Francisco earlier this week, the CEO of Dexcom relayed a strong desire to sell CGM systems directly to the consumers with possible pilots this year.
Kevin Sayer, Dexcom’s chairman president and CEO, was at J.P. Morgan’s annual healthcare conference in San Francisco earlier this week to present the latest financial results as well as describe what’s ahead for the company. The San Diego medical device company has emerged as the leader in the continuous glucose monitoring space.
Later, he sat down with MedCity News for an interview. One of the most notable exchanges involved his vision to bring the company’s CGM system directly to consumers.
Here is a slightly...